Question 1

What is the catalog number for 2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide?

Accepted Answer

The catalog number for 2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide is sc-341472.

Question 2

What sizes are available for 2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide?

Accepted Answer

2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide is available in the following size(s): 1 g.

Question 3

Is 2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide in stock?

Accepted Answer

2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

2-Biphenyl-4-yl-quinoline-4-carboxylic acid hydrazide

Product Specifications

Frequently Asked Questions

Explore Other Products

CD3e (B-B12), CF740 conjugate, 0.1mg/mL

CD45 / LCA (B-Cell Marker) (PTPRC/1461), CF568 conjugate, 0.1mg/mL

Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/3342), CF647 conjugate, 0.1mg/mL

TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2152), CF405S conjugate, 0.1mg/mL

TAG-72 / CA72.4 (B72.3 + CC49), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL